Skip to main content
Top

Cancer Causes & Control

Issue 9/2000

Content (15 Articles)

Joint effect of HPV16 with Chlamydia trachomatis and smoking on risk of cervical cancer: antagonism or misclassification (Nordic countries)

Matti Hakama, Tapio Luostarinen, Göran Hallmans, Egil Jellum, Pentti Koskela, Matti Lehtinen, Steinar Thoresen, Linda Youngman, Timo Hakulinen

Is there an association between alcohol intake or smoking and small bowel adenocarcinoma? Results from a European multi-center case–control study

Linda Kaerlev, Peter Stubbe Teglbjaerg, Svend Sabroe, Henrik A. Kolstad, Wolfgang Ahrens, Mikael Eriksson, Pascal Guénel, Lennart Hardell, Guy Launoy, Enzo Merler, Franco Merletti, Andreas Stang, Jorn Olsen

Multiple primary breast and thyroid cancers: role of age at diagnosis and cancer treatments (United States)

Christopher I. Li, Mary Anne Rossing, Lynda F. Voigt, Janet R. Daling

Smoking and drinking cessation and risk of esophageal cancer (Spain)

Xavier Castellsagué, Nubia Muñoz, Eduardo De Stefani, Cesar G. Victora, M. Jesús Quintana, Roberto Castelletto, Pedro Anibal Rolón

Breast cancer following augmentation mammoplasty (United States)

Louise A. Brinton, Jay H. Lubin, Mary Cay Burich, Theodore Colton, S. Lori Brown, Robert N. Hoover

Physical activity and postmenopausal endometrial cancer risk (Sweden)

Tahereh Moradi, Elisabete Weiderpass, Lisa B. Signorello, Ingemar Persson, Olof Nyrén, Hans-Olov Adami

Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States)

Patricia F. Coogan, Lynn Rosenberg, Julie R. Palmer, Brian L. Strom, Paul D. Stolley, Ann G. Zauber, Samuel Shapiro

Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

Merja H. Ahonen, Leena Tenkanen, Lyly Teppo, Matti Hakama, Pentti Tuohimaa

Diet and prostate cancer risk in a cohort of smokers, with a specific focus on calcium and phosphorus (Finland)

June M. Chan, Pirjo Pietinen, Mikko Virtanen, Nea Malila, Joseph Tangrea, Demetrius Albanes, Jarmo Virtamo

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine